ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.65
-0.30 (-1.37%)
At close: Feb 11, 2026

ScinoPharm Taiwan Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
17,11917,43620,87620,12419,49222,813
Market Cap Growth
-2.48%-16.48%3.73%3.25%-14.56%8.46%
Enterprise Value
15,04514,13617,53016,52716,27519,607
Last Close Price
21.6521.6025.6024.3723.1726.56
PE Ratio
90.1451.3872.7256.9880.0680.88
Forward PE
56.97108.27102.5252.6030.88115.41
PS Ratio
5.365.126.556.177.067.40
PB Ratio
1.561.662.011.931.852.17
P/TBV Ratio
1.561.662.021.931.862.17
P/FCF Ratio
69.0937.04-37.9399.7629.77
P/OCF Ratio
33.7923.2290.3226.0138.2324.11
EV/Sales Ratio
4.714.155.505.065.896.36
EV/EBITDA Ratio
22.2617.8523.0719.9324.8325.99
EV/EBIT Ratio
90.0444.0355.7440.7656.3952.18
EV/FCF Ratio
60.7230.03-31.1583.2925.59
Debt / Equity Ratio
0.070.060.060.070.050.06
Debt / EBITDA Ratio
1.150.830.800.800.830.75
Debt / FCF Ratio
3.131.44-1.282.850.75
Net Debt / Equity Ratio
-0.19-0.33-0.32-0.35-0.33-0.33
Net Debt / EBITDA Ratio
-3.16-4.41-4.37-4.36-5.38-4.61
Net Debt / FCF Ratio
-8.37-7.4189.04-6.82-18.04-4.54
Asset Turnover
0.270.290.270.280.240.26
Inventory Turnover
1.091.321.461.591.141.49
Quick Ratio
4.836.286.526.168.046.59
Current Ratio
7.858.618.757.8710.738.62
Return on Equity (ROE)
1.80%3.25%2.76%3.37%2.31%2.71%
Return on Assets (ROA)
0.87%1.70%1.66%2.15%1.53%2.00%
Return on Invested Capital (ROIC)
1.62%3.75%3.73%4.73%3.31%4.03%
Return on Capital Employed (ROCE)
1.40%2.90%2.90%3.70%2.60%3.40%
Earnings Yield
1.13%1.95%1.38%1.75%1.25%1.24%
FCF Yield
1.45%2.70%-0.18%2.64%1.00%3.36%
Dividend Yield
1.62%1.62%1.17%1.48%2.07%1.88%
Payout Ratio
143.39%69.91%99.17%107.46%162.39%75.69%
Buyback Yield / Dilution
0.03%-0.07%0.04%-0.05%-0.01%-0.01%
Total Shareholder Return
1.64%1.55%1.22%1.43%2.06%1.87%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.